— Know what they know.
Not Investment Advice
Also trades as: 0QAH.L (LSE) · $vol 8M · 6MK.DE (XETRA) · $vol 0M · MRK.PA (PAR) · $vol 0M

MRK NYSE

Merck & Co., Inc.
1W: +2.2% 1M: +2.6% 3M: -5.2% YTD: +8.8% 1Y: +52.9% 3Y: +8.6% 5Y: +80.3%
$122.41
+6.53 (+5.64%)
 
Weekly Expected Move ±3.4%
$104 $108 $111 $115 $119
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 67 · $302.3B mcap · 2.47B float · 0.386% daily turnover · Short 45% of daily vol

Cash Flow Trends

Operating Cash Flow
$16.5B -23.3% ▼
5Y CAGR: +9.9%
Capital Expenditures
$4.1B -21.9% ▼
5Y CAGR: -2.6%
Free Cash Flow
$12.4B -31.7% ▼
5Y CAGR: +17.3%
Dividends Paid
$8.2B -4.3% ▼
Buybacks
$5.1B -289.3% ▼
Net Change in Cash
$1.4B -78.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$12.4B$14.5B$365M$17.1B$18.3B
Depreciation & Amort.$3.2B$3.9B$3.9B$4.5B$5.8B
Stock-Based Comp.$479M$541M$645M$761M$0
Change in Working Capital-$3.8B-$2.8B-$2.2B-$3.7B-$7.0B
Other Non-Cash Items$1.7B$4.5B$12.2B$4.0B$1.0B
Operating Cash Flow$14.1B$19.1B$13.0B$21.5B$16.5B
— Investing Activities —
Capital Expenditures-$4.4B-$4.4B-$3.9B-$3.4B-$4.1B
Acquisitions (Net)-$12.9B-$121M-$12.0B-$4.1B-$10.0B
Investment Purchases-$1M-$1.2B-$955M-$519M-$1.2B
Investment Sales$1.0B$721M$1.7B$377M$1.7B
Other Investing-$225M$32M$1.1B-$127M-$58M
Investing Cash Flow-$16.6B-$5.0B-$14.1B-$7.7B-$13.7B
— Financing Activities —
Net Debt Issuance$1.6B-$2.3B$4.2B$2.3B$11.4B
Stock Repurchased-$840M$0-$1.3B-$1.3B-$5.1B
Dividends Paid-$6.6B-$7.0B-$7.4B-$7.8B-$8.2B
Other Financing$8.4B-$240M-$203M-$195M-$131M
Financing Cash Flow$2.6B-$9.1B-$4.8B-$7.0B-$1.9B
Net Change in Cash$14M$4.6B-$5.9B$6.4B$1.4B
Cash End of Period$8.2B$12.8B$6.9B$13.3B$14.7B
Free Cash Flow$9.7B$14.7B$9.1B$18.1B$12.4B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms